Skip to main content

Table 3 Mortality (Cox regression)

From: Mortality in patients treated with intravitreal bevacizumab for age-related macular degeneration

Variables B S.E. Wald (df = 1) p-value OR
Gender (male) .053 .043 1.507 .220 1.054
Age start (Year) .013 .004 12.927 .000 1.013
Socioeconomic (low) .083 .057 2.093 .148 1.086
Smoking .162 .061 7.135 .008 1.176
Alcohol .323 .240 1.809 .179 1.381
Hypertension .032 .056 .322 .570 1.032
Diabetes .015 .046 .106 .745 1.015
Obesity .071 .054 1.724 .189 1.073
Congestive heart failure .172 .055 9.779 .002 1.187
Liver cancer .775 .516 2.255 .133 2.170
Ischemic heart disease .000 .046 .000 .993 1.000
Cerebrovascular accident .153 .051 9.065 .003 1.166
Bevacizumab use .527 .043 153.744 .000 1.694